Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
A global biotechnology company developing therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
Poland
BMX
Biomea Fusion, Inc. Logo
A clinical-stage biopharma developing oral drugs for diabetes and obesity.
United States of America
BMEA
BIOMERICA INC Logo
Develops in-vitro diagnostic and therapeutic products for chronic diseases.
United States of America
BMRA
bioMérieux Logo
A global leader in in vitro diagnostics for clinical and industrial applications.
France
BIM
BiomX Inc. Logo
Clinical-stage company developing phage therapies to target harmful bacteria.
United States of America
PHGE
BIONEERCORPORATION Logo
Develops and manufactures molecular biology products for research and diagnostics.
South Korea
064550
BioNTech SE Logo
Biotechnology company developing immunotherapies for cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.
Denmark
BIOPOR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.